Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06561932

A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
EBR Systems, Inc. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

Assess the safety and efficacy of the co-implantation of the WiSE CRT System with an intracardiac pacemaker to provide totally leadless CRT.

Detailed description

The WiSE CRT System is an implantable cardiac system to provide left ventricular (LV) pacing stimulation in conjunction with a co-implanted system that provides right ventricular (RV) stimulation. In combination, the devices deliver biventricular (BiV) pacing. Single-arm, prospective, multicenter, observational study.

Conditions

Interventions

TypeNameDescription
DEVICEWiSE CRT SystemThe WiSE CRT System is an implantable cardiac system to provide left ventricular (LV) pacing stimulation in conjunction with a co-implanted system that provides right ventricular (RV) stimulation. In combination, the devices deliver biventricular (BiV) pacing.

Timeline

Start date
2025-12-18
Primary completion
2027-04-01
Completion
2027-04-01
First posted
2024-08-20
Last updated
2026-02-06

Locations

4 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT06561932. Inclusion in this directory is not an endorsement.